BrightSpring Health Services, Inc. Common Stock
$ 41.21
-6.32%
20 Mar - close price
- Market Cap 7,915,796,000 USD
- Current Price $ 41.21
- High / Low $ 43.93 / 39.91
- Stock P/E 91.58
- Book Value 9.20
- EPS 0.45
- Next Earning Report 2026-05-01
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.03 %
- ROE 0.06 %
- 52 Week High 44.87
- 52 Week Low 15.48
About
BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in meeting the intricate needs of a diverse patient population, including individuals with intellectual and developmental disabilities as well as those requiring rehabilitation. The company emphasizes personalized care solutions backed by a highly trained workforce, ensuring exceptional patient outcomes. BrightSpring's strategic investment in technology and commitment to quality enable it to thrive in the growing market for value-based care, making it well-positioned to capitalize on the ongoing evolution of the healthcare landscape.
Analyst Target Price
$52.60
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-26 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-03-06 | 2024-11-01 | 2024-08-02 | 2024-05-02 | 2024-02-29 |
| Reported EPS | 0.33 | 0.17 | 0.13 | 0.19 | 0.22 | 0.11 | 0.1 | 0.12 | 0.14 |
| Estimated EPS | 0.25 | 0.22 | 0.22 | 0.091 | 0.21 | 0.17 | 0.17 | 0.07 | 0.09 |
| Surprise | 0.08 | -0.05 | -0.09 | 0.099 | 0.01 | -0.06 | -0.07 | 0.05 | 0.05 |
| Surprise Percentage | 32% | -22.7273% | -40.9091% | 108.7912% | 4.7619% | -35.2941% | -41.1765% | 71.4286% | 55.5556% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-01 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.32 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: BTSG
2026-03-17 12:08:55
BrightSpring Health Services (BTSG) has seen increased investor attention following its presentation at the Leerink Global Healthcare Conference, where it discussed efficiency efforts and specialty pharmacy growth. Analysts have upgraded the stock, which is currently trading at a 31% discount to their target despite a 124% increase over the past year. While one narrative suggests it is 23.4% undervalued with a fair value of $51.00, another view highlights its high P/E ratio of 74.9x, indicating potential overvaluation on current earnings.
2026-03-07 02:52:19
Lisa Nalley, an insider at BrightSpring Health Services (NASDAQ:BTSG), recently sold 30,000 shares of the company's stock for $1,234,500, reducing her stake by over 21%. This sale comes amidst mixed fundamentals for the company, including strong revenue growth but an EPS miss, and the stock trading at a high P/E ratio near its 52-week high. Despite the insider sale, institutional investors have significantly increased their holdings, and analysts generally maintain a positive outlook with an average target price of $44.08.
2026-03-07 02:52:19
Jon Rousseau, an insider at BrightSpring Health Services (NASDAQ:BTSG), sold 220,000 shares of the company's stock for approximately $9.05 million. This transaction reduced his stake by 17.69%. Despite mixed Q4 fundamentals, with revenue up but EPS missing estimates and a high P/E ratio, the company has received "Buy" ratings from analysts and significant institutional investment, leading to a consensus target price of $44.08.
2026-03-06 10:53:02
Segall Bryant & Hamill LLC recently increased its stake in BrightSpring Health Services (NASDAQ:BTSG) by 51.7%, purchasing an additional 42,840 shares to now own 125,768 shares valued at approximately $3.72 million. Despite a slight EPS miss last quarter, BrightSpring exceeded revenue expectations and analysts maintain a "Buy" rating with an average target price around $44.08, following several increased price targets from firms like Wells Fargo and Mizuho. The company's stock has seen positive sentiment from analysts and upward earnings estimate revisions.
2026-03-06 08:53:02
Latham & Watkins LLP advised on BrightSpring Health Services, Inc.'s secondary offering of 20,000,000 shares of common stock at US$41.15 per share by certain selling stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. BrightSpring itself is not selling shares in this offering, and all proceeds will go to the selling stockholders. The offering is expected to close on March 4, 2026, with Latham's Capital Markets team, led by partners Marc Jaffe, Ian Schuman, and Kaj Nielsen, representing the underwriter.
2026-03-05 18:53:02
BrightSpring Health Services, Inc. (BTSG) is showing significant upside potential due to remarkably improving earnings outlooks and rising analyst optimism. The company has a Zacks Rank #1 (Strong Buy) indicating expected outperformance, with strong upward revisions in consensus estimates for both the upcoming quarter and the full year. This positive trend, correlated with near-term stock price movements, suggests further gains for investors.
